Stryker Stock Analysis (NYSE:SYK)

Add to My Stocks
$126.34 $0.59 (0.47%) SYK stock closing price Feb 17, 2017 (Closing)
Watch Robo Advisor Video of SYK Stock Analysis
Stryker
Updated on : Feb 17, 2017
previous close
SYK 126.3 (0%)
S&P 500 2351.2 (0%)
Closing Price On: Feb 17, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q4
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
16.3%
Sector Average:
-1.1%
5 Quarter Net Profit
Net Margins
2016-Q4
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
6.91B
Debt/Equity Ratio:
 0.72
Compared to the industry
Cash Flow
Operating cash flow:
$648M
Net Income:
$510M
Dividend Yield
SYK dividend yield:
1.24%
PROS      CONS
Operating Margins
Net Margins
ROIC
ROE
FCF Margin
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
SYK PS :
4.2
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
13%
Return on Equity:
18.2%
Free Cash Flow Margin:
16%
Double Tap To Exit Full Screen
0:00
/

Stryker Analysis Video

392 6 2

View Stryker stock analysis video. This is our SYK analyst opinion covering the buy and sell arguments for SYK stock.

Stryker Corporation Stock Rating (3.7/5)

Our Stryker stock opinion is based on fundamentals of the company. This Stryker stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy SYK stock?

  • Stryker had a healthy average operating margin of 16.3% over the last 4 quarters.
  • Net margins came in at average 14.5% for Stryker over the last twelve months.
  • Stryker has an attractive ROIC (Return on Invested Capital) of 13%
  • Return On Equity (ROE) which is a measure of the company's profitability, looks great for Stryker at 18.2%.
  • The company has a healthy free cash flow margin of 16%.

Should you sell SYK stock?

  • With a debt/equity ratio of  0.72, Stryker is highly leveraged in comparison to Medical peers.

Comments on this video and Stryker stock